Sobel Alan D. purchased $15K of CTSO
Sobel Alan D. purchased 2,500 shares of Cytosorbents Corp (CTSO) at an average of $6.10 ($6.01–$6.12) across 3 trades on 2026-09-15.
How this was made
The 30-second read
Why it matters
The director's purchase modestly raises his ownership, but the size is too small to indicate a material shift.
Market read
Routine insider buy with limited trading relevance; may be of interest to micro‑cap traders monitoring insider activity.
What to watch
If the director has access to upcoming product approvals, the buy might pre‑empt a catalyst not yet public.
Background
Form 4 filings disclose insider transactions; they are primary sources for insider activity.
Ticker impact
Director Alan D. Sobel purchased 2,500 shares of Cytosorbents for $15,254, increasing his stake to 9,887 shares.
Minimal upward pressure, unlikely to move the stock materially.
The transaction size is modest relative to market cap and represents a routine 10b5‑1‑free purchase by a director.
Market effects
No significant sector impact; Cytosorbents operates in a niche biotech filtration market.
Limited to U.S. small‑cap investors.
Negligible.
Counterpoint
The purchase could be a signal of confidence despite the small amount, suggesting potential upside.
Key entities
- CompanyCytosorbents Corp
US‑listed biotech company (ticker CTSO) focused on blood purification technologies.
- InsiderAlan D. Sobel
Director of Cytosorbents who executed the purchase.
